Genetic mutations of p53 and k-ras in gastric carcinoma patients from Hunan, China

Tumor Biology

Volumn 32, Issue 2, 2011, Pages 367-373

  Chen, Han Chun ^a   Chen, Hui Juan ^a   Khan, Md Asaduzzaman ^a   Rao, Zhou Zhou ^a   Wan, Xin Xing ^a   Tan, Bo ^a   Zhang, Dian Zheng ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

Author keywords

Gastric carcinoma; k ras mutation; p53 mutation; Single strand conformation polymorphism

Indexed keywords

GENOMIC DNA; K RAS PROTEIN; PROTEIN P53;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CHINA; CODON; CONTROLLED STUDY; EXON; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE INSERTION; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; ONCOGENE K RAS; POINT MUTATION; POLYMERASE CHAIN REACTION; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; STOMACH CARCINOMA; TUMOR SUPPRESSOR GENE; ALLELE; CASE CONTROL STUDY; ETHNOLOGY; GENETICS; MIDDLE AGED; ONCOGENE RAS; STOMACH TUMOR;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; CHINA; CODON; EXONS; FEMALE; FRAMESHIFT MUTATION; GENES, P53; GENES, RAS; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; STOMACH NEOPLASMS;

EID: 79953786463     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-010-0129-2     Document Type: Article

References (30)

1. Robins SL, Cotran RS. Neoplasia. In: Kumar V, Abbas AK, Fausto N, editors. Pathologic basis of disease. 7th ed. India: Thomson Press; 2009. p. 292-306.
2. Oliveira C, Seruca R, Carneiro F. Genetics, pathology, and clinics of familial gastric cancer. Int J Surg Pathol. 2006;14:21-33. (Pubitemid 43221612)
3. Gomez-Lazaro M, Fernandez-Gomez FJ, Jordán J. p53: twenty five years understanding the mechanism of genome protection. J Physiol Biochem. 2004;60:287-307.
4. Hollstein M, Sidransky D, Vogelstein B, et al. p53 mutations in human cancers. Science. 1991;253:49-53. (Pubitemid 21917115)
5. Sud R, Wells D, Talbot IC, et al. Genetic alterations in gastric cancers from British patients. Cancer Genet Cytogenet. 2001;126:111-9. (Pubitemid 32453327)
6. Belyavskaya VA, Vardosanidze VK, Smirnova OY, et al. Genetic status of p53 in stomach cancer: somatic mutations and polymorphism of codon 72. Bull Exp Biol Med. 2006;141:243-6. (Pubitemid 43792718)
7. Kranenburg O. The KRAS oncogene: past, present, and future. Biochim Biophys Acta. 2005;1756:81-2. (Pubitemid 41773135)
8. Arber N, Shapira I, Ratan J, et al. Activation of c-K-ras mutations in human gastrointestinal tumors.Gastroenterology. 2000;118:1045-50.
9. Shepherd T, Tolbert D, Benedetti J, et al. Alterations in exon 4 of the p53 gene in gastric carcinoma. Gastroenterology. 2000;118:1039-44. (Pubitemid 30346980)
10. Chung WC, Lee KM, Lee BI, et al. P53 genetic polymorphism of gastric cancer in Korea. Korean J Intern Med. 2006;21:28-32. (Pubitemid 43732763)
11. Yi SY, Lee WJ. A p53 genetic polymorphism of gastric cancer: difference between early gastric cancer and advanced gastric cancer. World J Gastroenterol. 2006;12:6536-9. (Pubitemid 44742591)
12. Cañas M, Morán Y, Camargo ME, et al. TP53 codon 72 polymorphism and gastric cancer risk: a case-control study in individuals from the central-western region of Venezuela. Invest Clin. 2009;50:153-61.
13. Mojtahedi Z, Haghshenas MR, Hosseini SV, et al. p 53 codon 72 polymorphism in stomach and colorectal adenocarcinomas in Iranian patients. Indian J Cancer. 2010;47:31-4.
14. Hamajima N, Matsuo K, Suzuki T, et al. No associations of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro polymorphisms with the risk of digestive tract cancers in Japanese. Cancer Lett. 2002;181:81-5. (Pubitemid 34326437)
15. Günther T, Schneider-Stock R, Häckel C, et al. Mdm2 gene amplification in gastric cancer correlation with expression of Mdm2 protein and p53 alterations. Mod Pathol. 2000;13:621-6. (Pubitemid 30436797)
16. RuggeM, Shiao YH, Busatto G, et al. The p53 gene in patients under the age of 40 with gastric cancer: mutation rates are low but are associated with a cardiac location. Mol Pathol. 2000;53:207-10. (Pubitemid 30603076)
17. Fukui H, Takada M, Chiba T, et al. Concurrent occurrence of gastric adenocarcinoma and duodenal neuroendocrine cell carcinoma: a composite tumour or collision tumours ? Gut. 2001;48:853-6.
18. Yanez L, Groffen J, Valenzuela DM. c-K-ras mutations in human carcinomas occur preferentially in codon 12. Oncogene. 1987;1:315-8. (Pubitemid 17149194)
19. Yang M, Guo Y, Zhang X, et al. Interaction of P53 Arg72Pro and MDM2 T309G polymorphisms and their associations with risk of gastric cardia cancer. Carcinogenesis. 2007;28:1996-2001. (Pubitemid 47500614)
20. Cao YY, Ge H, Chen LQ, et al. Correlation of 53BP1 and p53 polymorphisms to susceptibility to esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma. Ai Zheng. 2007;26:1052-7.
21. Huang ZH, Hua D, Du X. Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy. Cancer Chemother Pharmacol. 2009;64:1001-7.
22. Davis LG, Dibner MD, Battey JF. Preparation of DNA from eukaryotic cells. In: Davis LG, Dibner MD, Battey JF, editors. Basic methods in molecular biology. New York: Elsevier; 1986. p. 42-50.
23. van Oijen MG, Slootweg PJ. Gain-of-function mutations in the tumor suppressor gene p53. Clin Cancer Res. 2000;6:2138-45. (Pubitemid 30399178)
24. Maekawa M, Nagaoka T, Taniguchi T, et al. Three-dimensional microarray compared with PCR-single-strand conformation polymorphism analysis/DNA sequencing for mutation analysis of K-ras codons 12 and 13. Clin Chem. 2004;50:1322-7. (Pubitemid 38970638)
25. Hongyo T, Buzard GS, Palli D, et al. Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy. Cancer Res. 1995;55:2665-72.
26. Karim S, Ali A. Correlation of p53 over-expression and lteration in p53 gene detected by polymerase chain reaction-single strand conformation polymorphism in adenocarcinoma of gastric cancer patients from India. World J Gastroenterol. 2009;15:1381-7.
27. Yokozaki H, Yasui W, Tahara E. Genetic and epigenetic changes in stomach cancer. Int Rev Cytol. 2001;204:49-95. (Pubitemid 32185170)
28. Finkelstein SD, Sayegh R, Christensen S, et al. Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type. Cancer. 1993;71:3827-38.
29. Cerottini JP, Caplin S, Saraga E, et al. The type of K-ras mutation determines prognosis in colorectal cancer. Am J Surg. 1998;175:198-202. (Pubitemid 28173710)
30. Al-Mulla F, Going JJ, Sowden ET, et al. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality. J Pathol. 1998;185:13013-8.